| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Christopher Heeschen | Q18347525 |
| P2860 | cites work | Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor | Q24560244 |
| N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes | Q28171451 | ||
| Placental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1): novel therapeutic targets for angiogenic disorders | Q28204731 | ||
| Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders | Q28646428 | ||
| Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction | Q29618673 | ||
| B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study | Q30885744 | ||
| Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets. | Q33183129 | ||
| Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses | Q33910496 | ||
| A classification of unstable angina revisited | Q33958256 | ||
| Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. | Q34136366 | ||
| C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease | Q34311841 | ||
| Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes | Q34401659 | ||
| Acute coronary syndrome without ST elevation: implementation of new guidelines | Q34436586 | ||
| Clinical application of C-reactive protein for cardiovascular disease detection and prevention | Q35054464 | ||
| Update on C-reactive protein as a risk marker in cardiovascular disease | Q35106730 | ||
| The platelet CD40L/GP IIb-IIIa axis in atherothrombotic disease | Q35197406 | ||
| In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor | Q37361775 | ||
| Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections | Q39474763 | ||
| C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany | Q40524614 | ||
| Soluble CD40L: risk prediction after acute coronary syndromes | Q40568978 | ||
| N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arte | Q40576611 | ||
| Angiographic findings in patients with refractory unstable angina according to troponin T status | Q41694239 | ||
| Early expression of angiogenesis factors in acute myocardial ischemia and infarction | Q41722694 | ||
| Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial | Q41735567 | ||
| Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes | Q43815690 | ||
| Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy | Q44075631 | ||
| Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events | Q44216708 | ||
| The Prognostic Value of Serum Troponin T in Unstable Angina | Q44463743 | ||
| Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM Study Investigators. Platelet Receptor Inhibition in Ischemic Syndrome Management | Q45172489 | ||
| C-reactive protein levels and outcomes after statin therapy | Q45213511 | ||
| Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease | Q45213515 | ||
| Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. | Q45238823 | ||
| Prognostic value of placental growth factor in patients with acute chest pain | Q47237254 | ||
| Prognostic role of troponin T versus troponin I in unstable angina pectoris for cardiac events with meta-analysis comparing published studies | Q47913580 | ||
| C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction | Q47974191 | ||
| N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation | Q48532255 | ||
| The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes | Q48766104 | ||
| The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. | Q52962713 | ||
| Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. | Q53359026 | ||
| Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia | Q56945357 | ||
| Impact of Diabetes on Long-Term Prognosis in Patients With Unstable Angina and Non–Q-Wave Myocardial Infarction | Q58040699 | ||
| The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina | Q58230388 | ||
| Soluble CD40 Ligand in Acute Coronary Syndromes | Q58816350 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | acute coronary syndrome | Q266018 |
| biomarker | Q864574 | ||
| P304 | page(s) | 122-127 | |
| P577 | publication date | 2005-10-01 | |
| P1433 | published in | Diabetes and Vascular Disease Research | Q5270121 |
| P1476 | title | Biomarkers in acute coronary syndromes and their role in diabetic patients | |
| P478 | volume | 2 |
| Q37385494 | Berberine activates peroxisome proliferator-activated receptor gamma to increase atherosclerotic plaque stability in Apoe-/- mice with hyperhomocysteinemia |
| Q45845227 | Lentivirus-mediated RNA interference of chymase increases the plaque stability in atherosclerosis in vivo |
| Q46119967 | Seemingly healthy 71-year-old men with minor elevations of cardiac troponin I and at risk of premature death in CVD have elevated levels of NT-proBNP: report from the ULSAM study |
Search more.